Comparing Prism Adaptation Training With and Without TENS to Minimize Unilateral Spatial Neglect
Launched by KETTERING HEALTH NETWORK ·
Trial Information
Current as of September 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This is a small pilot study asking whether adding Transcutaneous Electrical Nerve Stimulation (TENS) to Prism Adaptation Therapy (PAT) helps people who have trouble paying attention to one side of their body or space after a stroke. PAT uses special prism glasses and reaching tasks to retrain spatial attention, while TENS provides gentle electrical stimulation to the affected arm to boost sensory awareness. The researchers will compare two groups over about 8–12 weeks of therapy: PAT combined with TENS versus PAT alone. They’ll look at changes in neglect and arm movement using two main tests: the Catherine Bergego Scale (CBS) for neglect and the Wolf Motor Function Test (WMFT) for arm function.
Who can join? Adults who have had a stroke and score at least 1 on the CBS (meaning some neglect is present) and can consent to participate. Exclusions include having more than two strokes, a seizure disorder, certain mental illnesses, cancer in the affected arm, a pacemaker or defibrillator, or not feeling the affected arm. The study is sponsored by Kettering Health Network and is not yet recruiting, with an estimated start around late 2025 and a planned completion around late 2027. About 20 people are expected to enroll. If you join, you’ll be randomly assigned to PAT+TENS or PAT alone and receive supervised therapy; safety and progress will be monitored. Results aren’t available yet, but when finished, researchers plan to share overall findings and may provide data to other researchers on request.
Gender
ALL
Eligibility criteria
About Kettering Health Network
Kettering Health Network is a comprehensive healthcare system dedicated to enhancing the health and well-being of the communities it serves through innovative clinical research and patient-centered care. With a commitment to advancing medical knowledge and improving treatment outcomes, Kettering Health Network engages in a wide range of clinical trials across various therapeutic areas. The organization combines state-of-the-art facilities, a multidisciplinary team of experienced professionals, and a patient-centric approach to ensure the highest standards of safety and efficacy in its research endeavors. By fostering collaboration between researchers, healthcare providers, and patients, Kettering Health Network aims to translate cutting-edge research into meaningful healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Rachelle M Janning, OTD, MS, OTR/L
Principal Investigator
Kettering Health/Northern Kentucky University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported